LOADING SNAPSHOT
Fetching the books…
For commercial pharma: watch patent cliffs and competition. For pre-revenue biotech: cash runway and trial readouts.
Not enough positive signals yet. Track for re-rating or fundamental improvement.
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin | Source |
|---|---|---|---|---|---|---|
| 2020-12-31 | — | — | — | — | — | 20-F ↗ |
| 2021-12-31 | — | — | $-2.98M | $-3.22M | — | 20-F ↗ |
| 2022-12-31 | — | — | $-10.55M | $-10.49M | — | 20-F ↗ |
| 2023-12-31 | — | — | $-12.05M | $-10.11M | — | 20-F ↗ |
| 2024-12-31 | — | — | $-9.90M | $-10.21M | — | 20-F ↗ |
| 2025-12-31 | — | — | $-11.09M | $-11.13M | — | 20-F ↗ |
No business description published.